Here are the latest quarterly results of WYETH. For more details, see the WYETH financial fact sheet and WYETH share price and chart. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Dec-12 |
3
Mar-13 |
3
Jun-13 |
3
Sep-13 |
3
Dec-13 |
3
Mar-14 |
3
Jun-14 |
3
Sep-14 |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 1,709 | 1,819 | 1,671 | 1,714 | 1,613 | 1,796 | 1,928 | 2,080 | |
Other income | Rs m | 81 | 89 | 91 | 99 | 76 | 75 | 62 | 52 | |
Turnover | Rs m | 1,790 | 1,908 | 1,762 | 1,813 | 1,689 | 1,871 | 1,990 | 2,132 | |
Expenses | Rs m | 1,398 | 1,380 | 1,417 | 1,525 | 1,414 | 1,412 | 1,551 | 1,608 | |
Gross profit | Rs m | 311 | 439 | 254 | 189 | 199 | 384 | 377 | 472 | |
Depreciation | Rs m | 6 | 7 | 6 | 6 | 7 | 8 | 7 | 8 | |
Interest | Rs m | 2 | 2 | 0 | 0 | 0 | 1 | 0 | 3 | |
Profit before tax | Rs m | 384 | 519 | 339 | 282 | 267 | 451 | 432 | 513 | |
Tax | Rs m | 127 | 167 | 117 | 98 | 93 | 152 | 148 | 177 | |
Profit after tax | Rs m | 257 | 352 | 222 | 184 | 175 | 299 | 285 | 336 | |
Gross profit margin | % | 18.2 | 24.1 | 15.2 | 11.0 | 12.3 | 21.4 | 19.6 | 22.7 | |
Effective tax rate | % | 33.1 | 32.2 | 34.5 | 34.8 | 34.7 | 33.7 | 34.1 | 34.6 | |
Net profit margin | % | 15.0 | 19.4 | 13.3 | 10.7 | 10.8 | 16.7 | 14.8 | 16.1 | |
Diluted EPS | Rs | 11.3 | 15.5 | 9.8 | 8.1 | 7.7 | 13.2 | 12.5 | 14.8 | |
Diluted EPS (TTM) | Rs | 61.0 | 57.2 | 49.9 | 44.7 | 41.0 | 38.7 | 41.5 | 48.1 | |
![]() |
More Pharmaceuticals Company Quarterly Results: AMAR REMEDIES ALEMBIC STRIDES PHARMA SCIENCE DISHMAN PHARMA AJANTA PHARMA
Compare WYETH With: AMAR REMEDIES ALEMBIC STRIDES PHARMA SCIENCE DISHMAN PHARMA AJANTA PHARMA
Compare WYETH With: MYLAN (US) ACTAVIS (US) ADCOCK INGRAM (S. Africa) TEVA PHARMA (Israel)
Indian share markets witnessed huge selling pressure today and failed to hold on to their opening gains as profit booking and weakness across all sectors erased gains.
In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.
The pandemic failed to thwart Richa's investing success formula for 2020.
In this video, I'll show you a crucial chart that you need to check before you decide to sell any stock or index.
Our ace stock picker is ready to capitalise on a big growth opportunity.
More